Evidence map›Paper›PMID 26695431›Full record

ArticlePloS one2015

The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development.

Kate Morrow Guthrie, Sara Vargas, Julia G Shaw, Rochelle K Rosen, Jacob J van den Berg, Patrick F Kiser, Karen Buckheit, Dana Bregman, Lara Thompson, Kathleen Jensen and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Use of simulated vaginal and menstrual fluids to modelInternational journal of pharmaceutics: X · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Kate Morrow GuthrieCenters for Behavioral & Preventive Medicine, The Miriam Hospital, Providence, Rhode Island, United States of America.
Sara VargasCenters for Behavioral & Preventive Medicine, The Miriam Hospital, Providence, Rhode Island, United States of America.
Julia G ShawCenters for Behavioral & Preventive Medicine, The Miriam Hospital, Providence, Rhode Island, United States of America.
Rochelle K RosenCenters for Behavioral & Preventive Medicine, The Miriam Hospital, Providence, Rhode Island, United States of America.
Jacob J van den BergCenters for Behavioral & Preventive Medicine, The Miriam Hospital, Providence, Rhode Island, United States of America.
Patrick F KiserDepartment of Bioengineering, University of Utah, Salt Lake City, Utah, United States of America.
Karen BuckheitImQuest BioSciences, Frederick, Maryland, United States of America.
Dana BregmanCenters for Behavioral & Preventive Medicine, The Miriam Hospital, Providence, Rhode Island, United States of America.
Lara ThompsonCenters for Behavioral & Preventive Medicine, The Miriam Hospital, Providence, Rhode Island, United States of America.
Kathleen JensenCenters for Behavioral & Preventive Medicine, The Miriam Hospital, Providence, Rhode Island, United States of America.
Todd JohnsonDepartment of Bioengineering, University of Utah, Salt Lake City, Utah, United States of America.
Robert W BuckheitImQuest BioSciences, Frederick, Maryland, United States of America.
Miriam Hospital · USImQuest BioSciences (United States) · USUniversity of Utah · USBrown University · US

Funding

Preclinical User Accptability Studies Long Acting Vaginal Gels, Intravaginal RingU19AI077289 · NIAID · IMQUEST BIOSCIENCES · PI GUTHRIE, KATE M · 2008 to 2012
$6.7M
Advancing Reproductive Health: Qualitative Methods & Interdisciplinary MentorshipK24HD062645 · NICHD · MIRIAM HOSPITAL · PI GUTHRIE, KATE M · 2012 to 2016
$689k
NIAID NIH HHS U19 AI077289NICHD NIH HHS K24 HD062645
6 · The paper itself

Abstract

Intravaginal rings (IVRs) are currently under investigation as devices for the delivery of agents to protect against the sexual transmission of HIV and STIs, as well as pregnancy. To assist product developers in creating highly acceptable rings, we sought to identify characteristics that intravaginal ring users consider when making decisions about ring use or non-use. We conducted four semi-structured focus groups with 21 women (aged 18-45) who reported using an IVR in the past 12 months. Participants manipulated four prototype rings in their hands, discussed ring materials, dimensionality, and "behavior," and shared perceptions and appraisals. Five salient ring characteristics were identified: 1) appearance of the rings' surfaces, 2) tactile sensations of the cylinder material, 3) materials properties, 4) diameter of the cylinder, and 5) ring circumference. Pliability (or flexibility) was generally considered the most important mechanical property. Several ring properties (e.g., porousness, dimensionality) were associated with perceptions of efficacy. Women also revealed user behaviors that may impact the effectiveness of certain drugs, such as removing, rinsing and re-inserting the ring while bathing, and removing the ring during sexual encounters. As product developers explore IVRs as prevention delivery systems, it is critical to balance product materials and dimensions with use parameters to optimize drug delivery and the user experience. It is also critical to consider how user behaviors (e.g., removing the ring) might impact drug delivery.

Indexed as

Contraceptive Devices, FemaleDrug Delivery SystemsAdolescentAdultFemaleHIV InfectionsHumansMiddle AgedPregnancy

Identifiers

PMID26695431
PMCPMC4690611
OpenAlexW2211567330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.